Augmented efficacy of exogenous extracellular vesicles targeted to injured kidneys
Signal Transduct Target Ther
.
2020 Sep 14;5(1):199.
doi: 10.1038/s41392-020-00304-6.
Authors
Xiao-Jun Chen
1
2
,
Kai Jiang
1
,
Christopher M Ferguson
1
,
Hui Tang
1
,
Xiangyang Zhu
1
,
Amir Lerman
3
,
Lilach O Lerman
4
5
Affiliations
1
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA.
2
Department of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
3
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.
4
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA. lerman.lilach@mayo.edu.
5
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA. lerman.lilach@mayo.edu.
PMID:
32929058
PMCID:
PMC7490711
DOI:
10.1038/s41392-020-00304-6
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
MeSH terms
Animals
Extracellular Vesicles / metabolism*
Kidney Diseases / metabolism*
Kidney* / injuries
Kidney* / metabolism
Mice
Grants and funding
R01 DK102325/DK/NIDDK NIH HHS/United States
R01 DK120292/DK/NIDDK NIH HHS/United States
R01 DK122734/DK/NIDDK NIH HHS/United States